Stocks and Investing Stocks and Investing
Wed, August 16, 2023
Tue, August 15, 2023

Andrew Berens Maintained (VIRX) at Buy with Decreased Target to $5 on, Aug 15th, 2023


Published on 2024-10-28 05:55:34 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Securities, Maintained "Viracta Therapeutics, Inc." (VIRX) at Buy with Decreased Target from $10 to $5 on, Aug 15th, 2023.

Andrew has made no other calls on VIRX in the last 4 months.



There is 1 other peer that has a rating on VIRX. Out of the 1 peers that are also analyzing VIRX, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Tony Butler of "EF Hutton" Initiated at Strong Buy and Held Target at $10 on, Monday, July 31st, 2023

Contributing Sources